Yanan Wang

Yanan Wang

Auto-generated profile, based on publicly available information

Yanan Wang

Department of Critical Care Medicine, The Affiliated Jiangyin Hospital of Nantong University, Wuxi, 214400, People’s Republic of China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YYYongbing Yang
Yongbing Yang
YWYanan Wang
Yanan Wang
ZWZhongcheng Wang
Zhongcheng Wang
HYHuanyu Yan
Huanyu Yan
YGYi Gong
Yi Gong
SYShuo Yang
Shuo Yang

1 September 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YWYanan Wang
Yanan Wang
JZJianglin Zhao
Jianglin Zhao
YZYushi Zhang
Yushi Zhang
JSJi Shen
Ji Shen
YSYuan Shi
Yuan Shi
XZXuefeng Zhang
Xuefeng Zhang
Background: Cellular heterogeneity in sepsis complicates the identification of cell-specific therapeutic targets. We aimed to identify genetically supported candidate immunogenetic regulators associated with sepsis through integrative multi-omics analyses. Methods: We conducted an integrative observational multi-omics study combining single-cell expression quantitative trait locus-based Mendelian randomization (sc-eQTL MR), bulk transcriptomic survival analysis, genetic colocalization, single-cell RNA sequencing (scRNA-seq), and a prospective observational clinical cohort. Publicly available summary-level or de-identified datasets were analyzed, including FinnGen sepsis GWAS data (GWAS ID: finn-b-O15_PUERP_SEPSIS), OneK1K sc-eQTL data, bulk transcriptomic data (GSE65682), and scRNA-seq datasets (GSE167363 and GSE151263). For prospective validation, 30 consecutive adult patients admitted to the intensive care unit who fulfilled the Sepsis-3 criteria were enrolled at the Affiliated Jiangyin Hospital of Nantong University between January 2026 and April 2026. Peripheral blood was collected within 24 hours after fulfillment of the Sepsis-3 criteria. TYMP concentrations in plasma were quantified using ELISA. Results: TYMP showed a nominal inverse association with sepsis susceptibility in CD4 effector memory/TEMRA cells (OR = 0.644, P = 0.008) in the exploratory MR screening, while genetic colocalization suggested a shared genetic signal with sepsis susceptibility (PPH4 = 0.78). In an independent cohort of 30 patients with sepsis, plasma TYMP levels were significantly elevated in survivors than in non-survivors (124.9 ± 20.7 vs 109.6 ± 15.1 pg/mL, P = 0.033). TYMP exhibited prognostic value for 28-day mortality (AUC = 0.701, P = 0.042), and elevated TYMP expression was associated with improved survival (HR = 0.259, P = 0.029). Single-cell and pseudotime analyses associated TYMP-expressing CD4⁺T cells with immunoregulatory transcriptional programs involving hypoxia and TGFB1 signaling. Pseudotime analysis demonstrated dynamic transcriptional reprogramming toward an immunoregulatory state. Conclusion: Integrated genetic, transcriptomic, single-cell, and clinical analyses nominate TYMP as a genetically supported candidate protective immunoregulatory marker associated with CD4⁺T cells in sepsis.